Results 1 to 10 of about 31,363 (175)

Perspective on the Therapeutics of Anti-Snake Venom [PDF]

open access: yesMolecules, 2019
Snakebite envenomation is a life-threatening disease that was recently re-included as a neglected tropical disease (NTD), affecting millions of people in tropical and subtropical areas of the world. Improvement in the therapeutic approaches to envenomation is required to palliate the morbidity and mortality effects of this NTD. The specific therapeutic
Andrea Salazar   +2 more
exaly   +6 more sources

Is anti‐snake venom required for all snakebites: A case report [PDF]

open access: yesClinical Case Reports (discontinued), 2020
AbstractThe classification of snakebite is based on clinical examination and laboratory tests. In cases, of suspected hemotoxic snakebite, the anti‐snakebite venom (ASV) is administered based on 20‐minute whole blood clotting time. However, the use of ASV should be guided by the presence of bleeding diathesis along with raised clotting time.
Thinley Dorji
exaly   +5 more sources

Delayed Neurological Manifestation in Krait Bites Despite Anti-snake Venom Therapy. [PDF]

open access: yesCureus, 2022
A severe medical emergency that poses a life-threatening risk is envenomation from a snake bite. Among the several snake families, krait bites are known to result in neurological symptoms, including ptosis, headache, and sweating. A 12-year-old adolescent boy who had been bitten by a krait appeared in this instance.
Sawhney S   +5 more
europepmc   +3 more sources

Anti-snake Venom-Induced Kounis Syndrome: A Unique Case in the Emergency Department. [PDF]

open access: yesCureus, 2022
Kounis syndrome is the concurrence of acute coronary syndromes associated with allergic or hypersensitivity and anaphylactic or anaphylactoid triggers. Although it is not a rare diagnosis, the different presentations and afflictions of all ages, sex, and racial groups make it a diagnostic challenge.
Verma A   +4 more
europepmc   +3 more sources

Knowledge assessment of anti-snake venom among healthcare practitioners in northern Nigeria. [PDF]

open access: yesTher Adv Infect Dis, 2021
Introduction: Anti-snake venom (ASV) is the standard therapy for the management of snakebite envenoming (SBE). Therefore, the knowledge of ASV among healthcare practitioners (HCPs) is essential for achieving optimal clinical outcomes in snakebite management.
Bala AA   +11 more
europepmc   +6 more sources

Anti-snake venom potential of Clerodendrum serratum extracts on Bungarus caeruleus and Daboia russelii venom

open access: yesBangladesh Journal of Pharmacology, 2018
Anti-snake venom therapy is the only treatment for snake bite but leads to acute and chronic conditions which may be severe. The medicinal plants have gained importance over years to find an effective alternative to anti-snake venom.
Shwetha Vasudev   +3 more
doaj   +3 more sources

Severe Pediatric Snakebite With Coagulopathy and Compartment Syndrome: Conservative Management With Plasma Exchange. [PDF]

open access: yesClin Case Rep
Therapeutic plasma exchange was successfully used in a child with severe snakebite envenomation complicated by refractory venom‐induced consumptive coagulopathy and suspected compartment syndrome, leading to full recovery and avoidance of surgical intervention.
Al Muqbel ZM   +8 more
europepmc   +2 more sources

Characterization of Alpha-Bungarotoxin Antibodies Prepared by Different Strategies [PDF]

open access: yesToxins
The preparation of an antibody to treat snake envenomation requires a large amount of snake venom. In China, only four types of anti-snake venom sera are clinically available, and the production and immunization strategies for clinically approved anti ...
Huijuan Lu   +6 more
doaj   +2 more sources

Comparison of Different Dosing Protocols of Anti-Snake Venom (ASV) in Snake Bite Cases. [PDF]

open access: yesJ Clin Diagn Res, 2017
Considering the cost of Anti-Snake Venom (ASV) and irregularity in its supply, there is often a need to curtail doses of ASV, despite guidelines for management of snake bite. During June 2013 to September 2013, when ASV was in short supply, our institutional committee reviewed the overall hospital statistics of snake bite cases as well as scientific ...
Daswani BR   +5 more
europepmc   +4 more sources

From Snake Venom’s Disintegrins and C-Type Lectins to Anti-Platelet Drugs

open access: yesToxins, 2019
Snake venoms are attractive natural sources for drug discovery and development, with a number of substances either in clinical use or in research and development.
Philip Lazarovici   +2 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy